Epilepsy & Neurodevelopmental Disorders: New Guide for Understanding & Action

A new guide released on February 9th, International Epilepsy Day, aims to improve understanding and coordination of care for individuals with epilepsy and neurodevelopmental disorders (NDDs). The guide, published by the French interministerial delegation for the national strategy for neurodevelopmental disorders, seeks to address a historical disconnect in how these conditions are approached.

The document, titled “Epilepsies and Neurodevelopmental Disorders: Understanding and Acting,” is intended for a broad audience, including people living with epilepsy, their families and caregivers, and healthcare professionals across medical, social, and educational settings. Its core ambition, according to French Ministers Stéphanie Rist and Charlotte Parmentier-Lecocq, is to “improve information for all concerned parties… and foster a shared understanding of the specific issues linking epilepsy and NDDs.”

Epilepsy is a chronic neurological condition characterized by recurrent seizures. The guide details the diagnosis and management of epilepsy, while also highlighting a significant association with NDDs. Specifically, it notes an increased risk of epilepsy in individuals with pre-existing NDDs, and conversely, an increased risk of NDDs in those diagnosed with epilepsy.

This bidirectional relationship is a key focus of the new guidance. For years, the guide points out, epilepsy and NDDs have been treated as separate entities, managed within isolated systems. Étienne Pot, the interministerial delegate, emphasizes that this siloed approach has been detrimental. He describes the guide as “a call to action,” advocating for “a real transformation of practices, organizations, and perspectives.”

The release of this guide comes amidst growing global attention to both epilepsy and neurodevelopmental disorders. The World Health Organization (WHO) recognizes autism as a significant global health challenge, and is working to move beyond awareness towards concrete action. Autism is one example of an NDD frequently co-occurring with epilepsy.

Understanding the interplay between epilepsy and NDDs is crucial for several reasons. Individuals with both conditions often face more complex medical and social challenges than those with either condition alone. Diagnostic delays can be common, and appropriate treatment may require a multidisciplinary approach involving neurologists, developmental pediatricians, psychologists, and educators. The presence of an NDD can influence the type of seizures experienced, the response to anti-epileptic medications, and the overall prognosis.

Recent research has also highlighted potential risks associated with certain medications used to treat epilepsy, particularly valproate. The European Medicines Agency (EMA) has issued precautionary recommendations regarding the use of valproate in men, due to a potential risk of neurodevelopmental disorders in children born to fathers treated with the medication. This underscores the importance of careful consideration of risks and benefits when prescribing anti-seizure medications, especially for individuals of reproductive age.

Similarly, new expert guidance on the use of antiseizure medications during pregnancy, as reported by Neurology Advisor, emphasizes the need for individualized treatment plans that balance the risks of seizures with the potential effects of medication on the developing fetus. These developments further emphasize the complexity of managing epilepsy, particularly in vulnerable populations.

The French guide’s call for a more integrated approach to care is particularly relevant in light of these evolving understandings. Breaking down the silos between epilepsy and NDD services will require improved communication and collaboration among healthcare providers, as well as increased awareness and training for all professionals involved in the care of these individuals. It also necessitates a patient-centered approach that prioritizes the unique needs and goals of each person affected.

The guide represents a significant step towards addressing these challenges in France. Its principles – improved information, shared understanding, and integrated care – are applicable globally, as healthcare systems strive to provide more comprehensive and effective support for individuals with epilepsy and neurodevelopmental disorders. The emphasis on action, rather than simply awareness, signals a commitment to translating knowledge into tangible improvements in the lives of those affected.